SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.590+3.6%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: investingNideas who wrote (321)8/12/2010 4:06:16 PM
From: investingNideas   of 368
 
sigma-aldrich-corporation-q2-2010 part 2

"Dmitry, this is Jai. I think we have seen overall in the second the contribution both to our research business, which is really a much positive sign because as you know the projects that come to SAFC could be lumpy so the volume that we saw for all our products, especially the ones that we introduced new products especially the products that were related to our [zinc sys] nucleus technology, they’re all promising signs that the pharmaceutical industry is continuing to invest in basic research."

"You asked three questions here. I think first of all let me say the contribution of S animals is insignificant and small, not enough to break it up, number one. Second thing is I think that we are using the S animal facility really to get the models that we are building using our Zinc Finger Nuclease to the customers

Now I think how far do we invest in growing that area will depend on the success of the basic research models that we are building. So stay tuned"

seekingalpha.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext